Details of the Drug

General Information of Drug (ID: DMZ3X7F)

Drug Name
Fordadistrogene movaparvovec
Synonyms PF-06939927
Indication
Disease Entry ICD 11 Status REF
Duchenne muscular dystrophy 8C70.1 Phase 3 [1]
Drug Type
Gene therapy
Cross-matching ID
TTD ID
D34VAB

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Dystrophin (DMD) TT48MP6 DMD_HUMAN Not Available [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Duchenne muscular dystrophy
ICD Disease Classification 8C70.1
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Dystrophin (DMD) DTT DMD 1.15E-07 -1.07 -2.94
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 ClinicalTrials.gov (NCT05689164) Long-term Follow-up Safety and Efficacy Study in Participants With Duchenne Muscular Dystrophy Who Have Received Fordadistrogene Movaparvovec in a Preceding Clinical Study. U.S.National Institutes of Health.